Berkowitz Noahinsider trades
In SEC Form 4 filings, Berkowitz Noah is listed as Chief Medical Officer of Iovance Biotherapeutics, Inc. (IOVA). Berkowitz Noah reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 2.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| IOVAIovance Biotherapeutics, Inc. | Chief Medical Officer | 3 | Oct 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-02
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| IOVAIovance Biotherapeutics, Inc. | Sep 30 | Oct 2 | A · derivative | 135,000 | $14.82 | $2,000,700 | 135,000 | No | Form 4 |
| IOVAIovance Biotherapeutics, Inc. | Sep 30 | Oct 2 | A · derivative | 180,000 | $0.00 | $0 | 180,000 | No | Form 4 |
| IOVAIovance Biotherapeutics, Inc. | Sep 30 | Oct 2 | A · derivative | 135,000 | $0.00 | $0 | 135,000 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.